Toggle navigation
Home
Search
Services
Blog
Contact
About
SBIR Topic Number 021 Development of Human Cell Lines
Crespi, Charles
Gentest Corporation, Woburn, MA, United States
Search 27 grants from Charles Crespi
Search grants from Gentest Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Control of Programmed Replication fork Arrest by Chromosome Kissing
Synergistic actions by multiple Toll-like receptors in alcoholic liver disease
Northwestern University Clinical Trial Unit
CT Alcohol &Drug Abuse Commission Treatment Expansion
Metabolism and Function of the Fat-Soluble Vitamins
Recently added grants:
Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose
Targeting UHRF1 in combinational immunotherapy
Precision Therapy for Neonatal Brain Injury
Targeting ATRX-Deficient Pediatric GBM
Enhanced cellular therapy for neonatal stroke
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43ES011002-000
Application #
2308236
Study Section
Project Start
1991-06-20
Project End
Budget Start
1991-06-20
Budget End
1991-12-31
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Gentest Corporation
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1991
N43 ES
SBIR Topic Number 021 Development of Human Cell Lines
Crespi, Charles / Gentest Corporation
NIH 1991
N43 ES
SBIR Topic Number 021 Development of Human Cell Lines
Crespi, Charles / Gentest Corporation
Comments
Be the first to comment on Charles Crespi's grant